Form 10-Q
MERIT MEDICAL SYSTEMS INC filed this Form 10-Q on 08/09/2018
Document Outline
Entire Document (6332.8 KB)
Subdocument 1 - 10-Q - 10-Q
Page 1 - UNITED STATES
Page 2 - TABLE OF CONTENTS
Page 3 - PART I - FINANCIAL INFORMATION
Page 4 - CONSOLIDATED BALANCE SHEETS
Page 5 - CONSOLIDATED STATEMENTS OF INCOME
Page 6 - MERIT MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
Page 7 - CONSOLIDATED STATEMENTS OF CASH FLOWS
Page 8 - CONSOLIDATED STATEMENTS OF CASH FLOWS
Page 9 - MERIT MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
Page 10 - 4. Earnings Per Common Share (EPS).
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - 6. Revenue from Contracts with Customers.
Page 19 - Disaggregation of Revenue
Page 20 - 7. Segment Reporting.
Page 21 - Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments
Page 22 - 9. Income Taxes.
Page 23 - 2016 Term Loan and Revolving Credit Loans
Page 24 - Collateralized Debt Facility
Page 25 - Foreign Currency Risk
Page 26 - Balance Sheet Presentation of Derivatives.
Page 27 - Derivatives Not Designated as Hedging Instruments
Page 28 - 12. Fair Value Measurements.
Page 29 - N/A
Page 30 - 13. Goodwill and Intangible Assets.
Page 31 - 14. Commitments and Contingencies.
Page 32 - ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Page 33 - Disclosure Regarding Trademarks
Page 34 - OVERVIEW
Page 35 - N/A
Page 36 - Results of Operations
Page 37 - Endoscopy Sales
Page 38 - Operating Income
Page 39 - Net Income
Page 40 - LIQUIDITY AND CAPITAL RESOURCES
Page 41 - Cash flows used in investing activities.
Page 42 - Critical Accounting Policies and Estimates
Page 43 - N/A
Page 44 - Item 3. QUANTITATIVE AND QUALITATIVE DICSLOSURES ABOUT MARKET RISK
Page 45 - N/A
Page 46 - Interest Rate Risk.
Page 47 - Item 4. CONTROLS AND PROCEDURES
Page 48 - PART II - OTHER INFORMATION
Page 49 - The FDA regulatory clearance process is expensive, time-consuming and uncertain, and the failure to
Page 50 - We may be unable to accurately forecast customer demand for our products and manage our inventory.
Page 51 - ITEM 6. EXHIBITS
Page 52 - SIGNATURES
Subdocument 2 - EX-10.2 - EXHIBIT 10.2
Page 1 - Exhibit 10.2
Page 2 - Company
Page 3 - Third Party Proceedings
Page 4 - Reliance as a Safe Harbor
Page 5 - No Employment Rights
Page 6 - Selection of Counselbetween
Page 7 - Nonexclusivity
Page 8 - Severability
Page 9 - Duration
Page 10 - Continuation of Indemnity; Binding Effect
Page 11 - /s/ Raul Parra
Subdocument 3 - EX-10.3 - EXHIBIT 10.3
Page 1 - Exhibit 10.3
Page 2 - Code
Page 3 - Compensation
Page 4 - Stock Incentive and Retirement Plans
Page 5 - Termination of Employment
Page 6 - By the Executiveor Good ReasonGood Reason
Page 7 - Date of TerminationDate of Termination
Page 8 - Resignation for Good Reason or Termination without Cause in Connection with a Change in Control
Page 9 - Other Benefits
Page 10 - Termination for Cause or Resignation Other than for Good Reason on or after a Change in Control
Page 11 - Full Settlement
Page 12 - If to the Company
Page 13 - N/A
Subdocument 4 - EX-31.1 - EXHIBIT 31.1
Page 1 - N/A
Subdocument 5 - EX-31.2 - EXHIBIT 31.2
Page 1 - N/A
Subdocument 6 - EX-32.1 - EXHIBIT 32.1
Page 1 - N/A
Subdocument 7 - EX-32.2 - EXHIBIT 32.2
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (What's this?)
XBRL Viewer